Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuro Haruta

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|May 29, 2014
Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)Hirofumi Toi, Masanori Tsujie, Yuro Haruta, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2006
Pneumatosis cystoides intestinalis after alpha-glucosidase inhibitor treatment in a patient with interstitial pneumonitisAkiko Hisamoto, Takaaki Mizushima, Ken Sato, et al.
Current Drug Delivery|November 2, 2010
Endoglin-targeted cancer therapyBen K Seon, Akinao Haba, Fumihiko Matsuno, et al.
Immunologic Research|September 19, 2009
Receptor-targeted anticancer therapyBen K Seon, Yuro Haruta, Fumihiko Matsuno, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|May 29, 2014
Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105)Hirofumi Toi, Masanori Tsujie, Yuro Haruta, et al.
Internal Medicine (Tokyo, Japan)|February 18, 2006
Pneumatosis cystoides intestinalis after alpha-glucosidase inhibitor treatment in a patient with interstitial pneumonitisAkiko Hisamoto, Takaaki Mizushima, Ken Sato, et al.
Current Drug Delivery|November 2, 2010
Endoglin-targeted cancer therapyBen K Seon, Akinao Haba, Fumihiko Matsuno, et al.
Immunologic Research|September 19, 2009
Receptor-targeted anticancer therapyBen K Seon, Yuro Haruta, Fumihiko Matsuno, et al.
Pageof 1